ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,488Medicare Part D Prescriptions Filled, Including Refills

Rank: 229 out of 2061

$622K Total Retail Price of All Prescriptions

Rank: 451 out of 2061

1,423 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,423 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 1,423 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,929 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
OMEPRAZOLE 824 799 1 5
LISINOPRIL 595 576 2 2
LOVASTATIN 553 539 3 35
METOPROLOL TARTRATE 536 525 4 7
ATENOLOL 472 457 5 13
K-TAB 467 438 10 6 194
TRIAMTERENE-HYDROCHLOROTHIAZID 451 438 10 7 135
FUROSEMIDE 439 434 8 6
SIMVASTATIN 439 421 8 1
LEVOTHROID 436 425 10 10 178
LOSARTAN POTASSIUM 397 382 11 17
TRAMADOL HCL 386 379 12 18
LEVOTHYROXINE SODIUM 321 311 13 3
HYDROCODONE-ACETAMINOPHEN 310 297 S3 14 10
AMLODIPINE BESYLATE 297 282 15 4
GLIPIZIDE 279 263 16 55
ALENDRONATE SODIUM 237 233 17 25
RANITIDINE HCL 169 166 18 53
HYDROCHLOROTHIAZIDE 157 153 19 12
FLUTICASONE PROPIONATE 155 144 20 43
ALLOPURINOL 151 146 21 28
FLUOXETINE HCL 150 143 22 73
ATORVASTATIN CALCIUM 149 147 23 8
AZITHROMYCIN 124 117 24 34
GABAPENTIN 120 117 25 15
PROAIR HFA 117 108 26 40
OXYCODONE-ACETAMINOPHEN 117 106 S2 26 36
WARFARIN SODIUM 115 111 28 11
METFORMIN HCL 115 105 28 9
INSULIN SYRINGE 109 96 30 105
TERAZOSIN HCL 107 107 31 120
CLONIDINE HCL 106 97 32 52
TRAZODONE HCL 99 98 33 39
ISOSORBIDE MONONITRATE ER 99 99 33 42
CARVEDILOL 92 92 35 22
FLUOCINONIDE 87 80 36 267
DIGOXIN 86 86 37 56
FENTANYL 85 85 S2 38 84
PRAVASTATIN SODIUM 81 79 39 14
DONEPEZIL HCL 79 79 40 24
CLOPIDOGREL 79 79 40 29
NOVOLIN 70-30 78 74 42 213
QVAR 78 73 42 286
PAROXETINE HCL 68 59 44 61
DIPHENOXYLATE-ATROPINE 68 56 44 324
OXYBUTYNIN CHLORIDE 67 64 46 121
NOVOLIN N 61 59 47 184
PREDNISONE 61 59 47 32
PLAVIX 59 59 49 49
NAPROXEN 57 52 50 110
CIPROFLOXACIN HCL 54 53 51 54
MIRTAZAPINE 53 53 52 46
MUPIROCIN 52 51 53 238
PROPRANOLOL HCL 52 51 53 143
TRIAMTERENE-HCTZ 50 46 55 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.